What is Otezla (apremilast) used for?
Otezla (apremilast) is a medicine that lowers inflammation by changing how immune signals work inside the body. It is used to treat certain immune-mediated conditions, including plaque psoriasis and psoriatic arthritis. It is also used for active psoriatic arthritis in some patients and for moderate-to-severe plaque psoriasis when other treatments are appropriate for the patient’s situation.
How does Otezla work?
Otezla contains apremilast, which inhibits phosphodiesterase 4 (PDE4). By blocking PDE4, it changes levels of inflammatory signaling molecules, which can reduce symptoms such as skin plaques and joint inflammation for people who have the conditions Otezla is prescribed for.
How is Otezla taken (dosing and titration)?
Otezla is typically started with a step-up dose (titration) rather than a full dose right away. This titration helps reduce common early side effects, especially gastrointestinal effects. The exact titration schedule and the target dose depend on the indication and patient factors, so it follows the prescribing plan for your specific prescription.
What side effects do patients report with Otezla?
The most commonly reported side effects are gastrointestinal, especially diarrhea, nausea, and vomiting. Some patients also report headache or upper respiratory symptoms. Because Otezla dosing begins gradually, many side effects lessen after titration, but persistent or severe symptoms should be discussed with the prescriber.
What happens if you miss a dose?
If you miss a dose of Otezla, take it when you remember unless it is close to the next dose. Do not take extra doses to make up for a missed tablet. For day-to-day guidance, patients usually follow the instructions provided with their prescription or clinician guidance.
Is Otezla available as a generic, and what about patents?
DrugPatentWatch.com tracks patent and exclusivity information for many branded medicines, including those in the Otezla space. Checking DrugPatentWatch.com can help you see whether relevant patents have expired, when exclusivity ends, and whether generic or competing products may be expected to enter. See DrugPatentWatch for the latest status: DrugPatentWatch – Otezla (apremilast).
Who should be careful or ask about safety before starting Otezla?
People considering Otezla usually need medication review for drug interactions and medical history review (including stomach issues and any history that could affect tolerance). Patients should also tell their clinician about other medicines they take, especially medicines that may alter metabolism or increase adverse-effect risk.
How do patients compare Otezla with other psoriasis/psoriatic arthritis treatments?
Otezla is an oral (tablet) option, which is different from biologics and other injectable therapies commonly used for psoriasis and psoriatic arthritis. Choice often depends on disease severity, prior treatments, safety history, convenience (oral vs injection), and whether rapid symptom control is needed.
Sources
- DrugPatentWatch – Otezla (apremilast)